A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database

Journal of Urology

Volumn 173, Issue 4, 2005, Pages 1108-1111

  Mariappan, Paramananthan ^a   Smith, Gordon ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bladder neoplasms; Cystoscopy; G1Ta; Observation; Recurrence

Indexed keywords

ADULT; AGED; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DATA BASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA;

EID: 15044358608     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000149163.08521.69     Document Type: Article

References (20)

1. Konety, B. R. and Getzenberg, R. H.: Urine based markers of urological malignancy. J Urol, 165: 600, 2001
2. Wright, M. P. and Jones, D. J.: Surveillance for bladder cancer: the management of 4.8 million people. South-west Urologists. BJU Int, 85: 431, 2000
3. Soloway, M. S., Bruuck, D. S. and Kim, S. S.: Expectant management of small, recurrent, non invasive papillary bladder tumors. J Urol, 170: 438, 2003
4. Parmar, M. K., Freedman, L. S., Hargreave, T. B. and Tolley, D. A.: Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol, 142: 284, 1989
5. Leblanc, B., Duclos, A. J., Bérnard, F., Côté, J., Valiquette, L., Paquin, J. M. et al: Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol, 162: 1946, 1999
6. Oge, O., Erdem, E., Atsu, N., Ahin, A. and Ozen, H.: Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor. Eur Urol, 37: 271, 2000
7. Greene, L. F., Hamash, K. A. and Farrow, G. M.: Benign papilloma or papillary carcinoma of the bladder? J Urol, 110: 205, 1973
8. Thompson, R. A., Jr., Campbell, E. W., Jr., Kramer, H. C., Jacobs, S. C. and Naslund, M. J.: Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol, 149: 1010, 1993
9. Morris, S. B., Gordon, E. M., Shearer, R. J. and Woodhouse, C. R.: Superficial bladder cancer: for how long should a tumour-free patient have check cystoscopies? BJU, 75: 193, 1995
10. Smith, G., Elton, R. A., Chisholm, G. D., Newsam, J. E. and Hargreave, T. B.: Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. Br J Urol, 58: 659, 1986
11. Harmer, M. H.: TNM Classification of Malignant Tumours, 3rd edition. Geneva: International Union Against Cancer, 1978
12. Cheng, L., Neumann, R. M. and Bostwick, D. G.: Papillary urothelial neoplasm of low malignant potential. Clinical and biological implications. Cancer, 86: 2102, 1999
13. Fujii, Y., Kawakami, S., Koga, F., Naemoto, T. and Kihara, K.: Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int, 92: 559, 2003
14. Smith, J. A., Jr., Labasky, R. F., Cockett, A. T. K., Fracchia, J. A., Montie, J. E. and Rowland, R. G.: Bladder Cancer Clinical Guidelines Panel summary report on the management of non-muscle invasive bladder cancer (stages Ta, T1 and TIS). J Urol, 162: 1697, 1999
15. Prout, G. R., Jr., Barton, B. A., Griffin, P. P. and Friedell, G. H. for the National Bladder Cancer Group: Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol, 148: 1413, 1992
16. Holmäng, S., Hedelin, H., Anderstrom, C. and Johansson, S. L.: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol, 153: 1823, 1995
17. Bryan, R. T. and Wallace, D. M.: 'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours. BJU Int, 90: 846, 2002
18. Millán-Rodríguez, F., Chéchile-Toniolo, G., Salvador-Bayarri, J., Palou, J., Algaba, F. and Vicente-Rodríguez, J.: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol, 164: 680, 2000
19. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. et al: Superficial bladder cancer: progression and recurrence. J Urol, 130: 1083, 1983
20. Malmstrom, P.-U., Wijkstrom, H., Lundholm, C., Wester, K., Busch, C. and Norlen, B. J.: 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J Urol, 161: 1124, 1999